Synovics Pharmaceuticals (OTCPK:SYVC) - Stock Price, News & Analysis

SYVC Stock Overview

SYVC fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($4K)

Shares are highly illiquid

Latest financial reports are more than a year old

Synovics Pharmaceuticals, Inc. Competitors

Lucy Scientific Discovery

OTCPK:LSDI.F

US$8.8k

Item 9 Labs

OTCPK:INLB

US$701.0

BZAM

OTCPK:BZAM.F

US$270.0

Hero Technologies

OTCPK:HENC

US$563.0

Price History & Performance

Summary of all time highs, changes and price drops for Synovics Pharmaceuticals
Historical stock prices
Current Share Price	US$0.0001
52 Week High	US$0.0001
52 Week Low	US$0.000001
Beta	0
11 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	SYVC	US Pharmaceuticals	US Market
7D	0%	2.6%	0.5%
1Y	n/a	13.1%	30.7%

Return vs Industry: Insufficient data to determine how SYVC performed against the US Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how SYVC performed against the US Market.

Price Volatility

Is SYVC's price volatile compared to industry and market?
SYVC volatility
SYVC Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	9.9%
Market Average Movement	6.3%
10% most volatile stocks in US Market	16.3%
10% least volatile stocks in US Market	3.1%

Stable Share Price: SYVC has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine SYVC's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1983	n/a	Jyotindra Gange	n/a

Synovics Pharmaceuticals, Inc., through its subsidiaries, engages in the development, manufacture, and commercialization of generic over-the-counter (OTC) pharmaceutical products and generic prescription drug products primarily in the United States. The company’s OTC product categories include analgesics, cough, cold, antihistamines, asthma relief, and laxatives. It packages and distributes its products to chain drug stores, wholesalers, and distributors in the United States.

Synovics Pharmaceuticals, Inc. Fundamentals Summary

How do Synovics Pharmaceuticals's earnings and revenue compare to its market cap?
SYVC fundamental statistics
Market cap	US$3.65k
Earnings (TTM)	-US$5.04m
Revenue (TTM)	US$19.09m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is SYVC overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SYVC income statement (TTM)
Revenue	US$19.09m
Cost of Revenue	US$14.63m
Gross Profit	US$4.47m
Other Expenses	US$9.51m
Earnings	-US$5.04m

Last Reported Earnings

Jul 31, 2009

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did SYVC perform over the long term?

See historical performance and comparison